$26.72
0.34[1.29%]
At close: May 15
$26.72
0[0.00%]
After Hours: 4:00PM EDT
Cullinan Therapeutics
(NASDAQ:CGEM)Latest News for Cullinan Therapeutics Stock (NASDAQ:CGEM)
Cullinan Therapeutics Stock (NASDAQ: CGEM)
Categories: All
Wednesday, May 01, 2024
Monday, April 29, 2024
- Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day SessionAvi Kapoor - Apr 29, 2024, 1:04PM
- Cullinan Therapeutics shares are trading higher. The company announced the appointment of a new CFO.Benzinga Newsdesk - Apr 29, 2024, 11:46AM
- Tesla, Deciphera Pharmaceuticals, Heartland Financial And Other Big Stocks Moving Higher On MondayAvi Kapoor - Apr 29, 2024, 10:47AM
- Cullinan Therapeutics Announces Appointment Of Mary Kay Fenton As Chief Financial OfficerBenzinga Newsdesk - Apr 29, 2024, 7:06AM
Friday, April 26, 2024
- Cullinan Therapeutics shares are trading higher. The company this week announced that clinical data from its Phase 1 trial of CLN-619 in patients with advanced solid tumors will be presented at the 2024 ASCO Annual Meeting.Benzinga Newsdesk - Apr 26, 2024, 2:27PM
- Why Aon Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day SessionAvi Kapoor - Apr 26, 2024, 1:56PM
- 12 Health Care Stocks Moving In Friday's Intraday SessionBenzinga Insights - Apr 26, 2024, 12:31PM
- Skechers Reports Upbeat Earnings, Joins Tutor Perini, AppFolio, Newell Brands And Other Big Stocks Moving Higher On FridayAvi Kapoor - Apr 26, 2024, 10:45AM
Wednesday, April 24, 2024
- Why Is Cullinan Therapeutics Stock Trading Higher On Wednesday?Vandana Singh - Apr 24, 2024, 2:29PM
- Cullinan Therapeutics shares are trading higher after the company announced that clinical data from its Phase 1 trial of CLN-619 in patients with advanced solid tumors will be presented at the 2024 ASCO Annual Meeting.Benzinga Newsdesk - Apr 24, 2024, 12:22PM
- Hilton Worldwide Reports Upbeat Results, Joins Hasbro, Vertiv Holdings And Other Big Stocks Moving Higher On WednesdayAvi Kapoor - Apr 24, 2024, 11:19AM
- Cullinan Therapeutics To Present Clinical Data From Phase 1 Study Evaluating Novel Anti-MICA/B Antibody, CLN-619, As Monotherapy And In Combination With A Checkpoint Inhibitor In Patients With Advanced Solid Tumors At ASCO 2024Benzinga Newsdesk - Apr 24, 2024, 10:10AM
Wednesday, April 17, 2024
- Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionAvi Kapoor - Apr 17, 2024, 1:36PM
- BTIG Maintains Buy on Cullinan Oncology, Raises Price Target to $30Benzinga Newsdesk - Apr 17, 2024, 11:21AM
- United Airlines Reports Upbeat Results, Joins Children's Place, Interactive Brokers And Other Big Stocks Moving Higher On WednesdayAvi Kapoor - Apr 17, 2024, 10:55AM
- HC Wainwright & Co. Maintains Buy on Cullinan Oncology, Lowers Price Target to $29Benzinga Newsdesk - Apr 17, 2024, 5:36AM
Tuesday, April 16, 2024
- Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionAvi Kapoor - Apr 16, 2024, 2:17PM
- Cullinan Shifts Focus From Oncology To Autoimmune Disorders, Raises $280M Via EquityVandana Singh - Apr 16, 2024, 1:32PM
- HC Wainwright & Co. Maintains Buy on Cullinan Oncology, Lowers Price Target to $29Benzinga Newsdesk - Apr 16, 2024, 12:54PM
- UnitedHealth Reports Upbeat Earnings, Joins Cullinan Oncology, Ericsson And Other Big Stocks Moving Higher On TuesdayAvi Kapoor - Apr 16, 2024, 10:15AM
- Market-Moving news for April 16thBenzinga Newsdesk - Apr 16, 2024, 8:36AM
- 12 Health Care Stocks Moving In Tuesday's Pre-Market SessionBenzinga Insights - Apr 16, 2024, 8:07AM
- Cullinan Therapeutics shares are trading higher. The company announced its plan to expand into autoimmune diseases.Benzinga Newsdesk - Apr 16, 2024, 7:50AM
- Cullinan Therapeutics To Pursue Development Of CLN-978 In Autoimmune Diseases, With Systemic Lupus Erythematosus As First Indication; Discontinued Enrollment In Its B-NHL Study To Focus Ongoing Development On Autoimmune IndicationsBenzinga Newsdesk - Apr 16, 2024, 7:44AM
- Cullinan Therapeutics Announces Oversubscribed $280M Private PlacementBenzinga Newsdesk - Apr 16, 2024, 7:07AM
Monday, April 15, 2024
Thursday, March 14, 2024
- HC Wainwright & Co. Reiterates Buy on Cullinan Oncology, Maintains $34 Price TargetBenzinga Newsdesk - Mar 14, 2024, 12:44PM
- Cullinan Oncology: Q4 Earnings InsightsBenzinga Insights - Mar 14, 2024, 8:30AM
- Cullinan Oncology Q4 EPS $(0.54) Beats $(0.96) Estimate; Cash And Investments Of $468.3M As Of December 31, 2023 Continues To Provide Runway Into The Second Half Of 2026Benzinga Newsdesk - Mar 14, 2024, 7:16AM
Friday, March 01, 2024
Thursday, February 15, 2024
Tuesday, January 30, 2024
Monday, January 08, 2024
Thursday, December 14, 2023
Wednesday, November 08, 2023
Friday, November 03, 2023
Friday, October 06, 2023
Friday, August 11, 2023
Thursday, August 10, 2023
Wednesday, August 09, 2023
Friday, July 07, 2023
Thursday, June 15, 2023
- Analyst Expectations for Cullinan Oncology's FutureBenzinga Insights - Jun 15, 2023, 4:01PM
- Cullinan Oncology shares are trading higher after TD Cowen initiated coverage on the stock with an Outperform rating.Benzinga Newsdesk - Jun 15, 2023, 2:40PM
- Benzinga's Top Ratings Upgrades, Downgrades For June 15, 2023Benzinga Insights - Jun 15, 2023, 11:01AM